Eledon Pharmaceuticals, Inc. Restructuring Charges
Eledon Pharmaceuticals, Inc. (ELDN) reported Restructuring Charges of $2.30 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-03-24
- Eledon Pharmaceuticals, Inc. restructuring charges for the quarter ending 2020-12-31 was -$10.00K.
- Eledon Pharmaceuticals, Inc. restructuring charges for the quarter ending 2020-09-30 was $1.80M.
- Eledon Pharmaceuticals, Inc. restructuring charges for the quarter ending 2020-06-30 was $490.00K.
- Eledon Pharmaceuticals, Inc. restructuring charges for fiscal 2021 was $2.30M, a 0.79% increase from fiscal 2020.
- Eledon Pharmaceuticals, Inc. restructuring charges for fiscal 2020 was $2.28M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2021-12-31 | $2.30M 10-K · filed 2022-03-24 | |||
| 2020-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.79M derived: sum of 2 quarters · filed 2022-03-24 | $2.28M derived: sum of 3 quarters · filed 2022-03-24 | $2.28M 10-K · filed 2022-03-24 |
| 2020-09-30 | $1.80M 10-Q · filed 2021-11-12 | $2.29M derived: sum of 2 quarters · filed 2021-11-12 | $2.29M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $490.00K 10-Q · filed 2021-08-12 | $490.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |